Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carolin Helten

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
International Journal of Cardiology|December 31, 2023
Heparin dosing in patients with Impella-supported cardiogenic shockChristophe Vandenbriele, René M'Pembele, Lisa Dannenberg, et al.
Circulation Research|December 21, 2019
Rivaroxaban Reduces Arterial Thrombosis by Inhibition of FXa-Driven Platelet Activation via Protease Activated Receptor-1Tobias Petzold, Manuela Thienel, Lisa Dannenberg, et al.
Circulation|October 21, 2024
Targeting Sphingosine-1-Phosphate Signaling to Prevent the Progression of Aortic Valve DiseaseMarcel Benkhoff, Maike Barcik, Philipp Mourikis, et al.
Journal of Thrombosis and Haemostasis : JTH|November 17, 2024
Long-term FXa inhibition attenuates thromboinflammation after acute myocardial infarction and stroke by platelet proteome alterationAmin Polzin, Marcel Benkhoff, Manuela Thienel, et al.
Science Translational Medicine|May 21, 2025
Icosapent ethyl reduces arterial thrombosis by inhibition of cyclooxygenase-1-induced platelet reactivityPhilipp Mourikis, Marcel Benkhoff, Laura Wildeis, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
International Journal of Cardiology|December 31, 2023
Heparin dosing in patients with Impella-supported cardiogenic shockChristophe Vandenbriele, René M'Pembele, Lisa Dannenberg, et al.
Circulation Research|December 21, 2019
Rivaroxaban Reduces Arterial Thrombosis by Inhibition of FXa-Driven Platelet Activation via Protease Activated Receptor-1Tobias Petzold, Manuela Thienel, Lisa Dannenberg, et al.
Circulation|October 21, 2024
Targeting Sphingosine-1-Phosphate Signaling to Prevent the Progression of Aortic Valve DiseaseMarcel Benkhoff, Maike Barcik, Philipp Mourikis, et al.
Journal of Thrombosis and Haemostasis : JTH|November 17, 2024
Long-term FXa inhibition attenuates thromboinflammation after acute myocardial infarction and stroke by platelet proteome alterationAmin Polzin, Marcel Benkhoff, Manuela Thienel, et al.
Science Translational Medicine|May 21, 2025
Icosapent ethyl reduces arterial thrombosis by inhibition of cyclooxygenase-1-induced platelet reactivityPhilipp Mourikis, Marcel Benkhoff, Laura Wildeis, et al.
Pageof 4